SCHEMBL2763308

SCHEMBL2763308

O=C(O)C=CC(O)CCCO

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.52
BACE1 P56817 1/20 0.52
CAMK2A Q9UQM7 1/20 0.37
GABRP O00591 2/20 0.37
GABRD O14764 2/20 0.37
GABRA1 P14867 2/20 0.37
GABRB1 P18505 2/20 0.37
GABRG2 P18507 2/20 0.37
GABRB3 P28472 2/20 0.37
GABRA5 P31644 2/20 0.37
GABRA3 P34903 2/20 0.37
GABRA2 P47869 2/20 0.37
GABRB2 P47870 2/20 0.37
GABRA4 P48169 2/20 0.37
GABRE P78334 2/20 0.37
GABRA6 Q16445 2/20 0.37
GABRG1 Q8N1C3 2/20 0.37
GABRG3 Q99928 2/20 0.37
GABRQ Q9UN88 2/20 0.37
PTPN1 P18031 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL561406 0.92 ACHE (0.49) ACHEBACE1CAMK2AGABRPGABRD
SCHEMBL15286996 0.92 ACHE (0.49) ACHEBACE1CAMK2AGABRPGABRD
SCHEMBL27963352 0.92 ACHE (0.49) ACHEBACE1CAMK2AGABRPGABRD
SCHEMBL15287182 0.92 ACHE (0.49) ACHEBACE1CAMK2AGABRPGABRD
SCHEMBL4759937 0.92 ACHE (0.49) ACHEBACE1CAMK2AGABRPGABRD
SCHEMBL649787 0.92 ACHE (0.49) ACHEBACE1CAMK2AGABRPGABRD
SCHEMBL4745520 0.92 ACHE (0.49) ACHEBACE1CAMK2AGABRPGABRD
SCHEMBL5410871 0.86 ACHE (0.46) ACHEBACE1GABRPGABRDGABRA1
Adipic Acid SCHEMBL6760249 0.85 FFAR1 (0.55) ACHEBACE1CAMK2AGPR84FFAR1
SCHEMBL4732889 0.83 ACHE (0.52) ACHEBACE1MAPTCMKLR1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10131814-B2 Radiation-curable water-dispersible polyurethane (meth)acrylates BASF SE (DE) 2018-11-20 US claimed
EP-1274401-A4 STABLE PHARMACEUTICAL COMPOSITIONS CONTAINING 7-SUBSTITUTED-3,5-DIHYDROXYHEPTANOIC ACIDS OR 7-SUBSTITUTED-3,5-DIHYDROXYHEPTENOIC ACIDS TEVA PHARMA (IL) 2009-07-22 EP claimed
EP-1274401-A1 STABLE PHARMACEUTICAL COMPOSITIONS CONTAINING 7-SUBSTITUTED-3,5-DIHYDROXYHEPTANOIC ACIDS OR 7-SUBSTITUTED-3,5-DIHYDROXYHEPTENOIC ACIDS TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2003-01-15 EP claimed
EP-1268589-A1 ACRYLIC RUBBER LATEX HAVING BIMODAL PARTICLE DISTRIBUTION LG Chem Ltd. (KR) 2003-01-02 EP claimed
WO-2002055572-A1 ACRYLIC RUBBER LATEX HAVING BIMODAL PARTICLE DISTRIBUTION LG CHEM, LTD. (KR) 2002-07-18 WO claimed
WO-2001076566-A1 STABLE PHARMACEUTICAL COMPOSITIONS CONTAINING 7-SUBSTITUTED-3,5-DIHYDROXYHEPTANOIC ACIDS OR 7-SUBSTITUTED-3,5-DIHYDROXYHEPTENOIC ACIDS TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2001-10-18 WO claimed
US-20130237579-A1 STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ONE OR MORE HMG-COA REDUCTAS INHIBITIORS STANLEY TIMOTHY (GB) 2013-09-12 US disclosed
EP-2178515-A2 STABLE COMPOSITIONS Generics Ýuk¨Limited (GB) 2010-04-28 EP disclosed
WO-2009010787-A2 STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ONE OR MORE HMG-COA REDUCTASE INHIBITORS GENERICS [UK] LIMITED (GB) 2009-01-22 WO disclosed
EP-1644198-A1 INK JET RECORDING MEDIUM Ciba SC Holding AG (CH) 2006-04-12 EP disclosed
WO-2005005155-A1 INK JET RECORDING MEDIUM CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-01-20 WO disclosed
EP-1268589-A1 ACRYLIC RUBBER LATEX HAVING BIMODAL PARTICLE DISTRIBUTION LG Chem Ltd. (KR) 2003-01-02 EP disclosed
WO-2002055572-A1 ACRYLIC RUBBER LATEX HAVING BIMODAL PARTICLE DISTRIBUTION LG CHEM, LTD. (KR) 2002-07-18 WO disclosed
US-5387693-A Intermediates for inhibitors of cholesterol biosynthesis ORTHO PHARMACEUTICAL CORPORATION (US) 1995-02-07 US disclosed
US-5315012-A Prevention of hypercholesterolemia, hyperlipoproteinemia and atherosclerosis ORTHO PHARMACEUTICAL CORPORATION (US) 1994-05-24 US disclosed
US-5250561-A Anticholesterool agents; prevention of hyperlipoproteinemia and atherosclerosis ORTHO PHARMACEUTICAL CORPORATION (US) 1993-10-05 US disclosed
EP-0529854-A2 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-COA reductase inhibitors ORTHO PHARMACEUTICAL CORPORATION (US) 1993-03-03 EP disclosed
US-5134155-A Anticholesterol ORTHO PHARMACEUTICAL CORPORATION (US) 1992-07-28 US disclosed
US-4792614-A ANTIHYPER CHOLESTEROL AGENTS AMERICAN HOME PRODUCTS CORPORATION (US) 1988-12-20 US disclosed